UConn Health
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, UConn Health sits in the top decile of US sponsors by registered trial count (#168 of 15,742 sponsors by registered trial count).
UConn Health: 178 sponsored US clinical trials, 19 recruiting.
UConn Health sponsors 178 registered US clinical trials on ClinicalTrials.gov, 19 of them currently recruiting, and 132 completed. 25 of these trials are in Phase 3-4 (later-stage) and 23 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alcoholism, with 5 trials.
Top-decile sponsor footprint
UConn Health ranks in the top decile of sponsors by registered trial count (#168 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
132 of 151 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
178 total, page 3 of 4
Prize Contingency Management for Cocaine-Dependent Methadone Patients
NCT01401270
Adaptive Treatment for Adolescent Cannabis Use Disorders
NCT01656707
Effects of Thoracic Orthopedic Manual Therapy and Biopsychosocial Variables on Signs of Shoulder Impingement
NCT01743833
Improving Antihypertensive Medication Adherence
NCT01296594
Remote Monitoring and Contingency Management Reinforcement for Alcohol Abstinence
NCT01307345
Substance Use and Fitness
NCT01305902
Dutasteride for the Reduction of Alcohol Use in Male Drinkers
NCT01262287
Immediate vs Delayed Loading of Two Implants Supporting a Mandibular Over Denture
NCT01949298
Colonoscope Insertion Trial Protocol
NCT01324882
Extending Contingency Management's Benefits With Progressively Increasing Variable Interval Prize Reinforcement
NCT01184040
Reinforcing Exercise in Substance Abusing Patients
NCT01204879
Contingency Management for Promoting Weight Loss in University Students
NCT01053260
Breaking the Cycle IV: Military PTSD (MPTSD) Treatment Study
NCT01228539
Network Support for Alcohol Treatment 2
NCT01129804
Oocyte Cryopreservation Comparing Fresh and Vitrified Sibling Oocytes
NCT00986687
Periodontal Infection and Systemic Inflammation in Renal Patients
NCT01094639
Vitamin D Deficiency in Patients With Hypertension
NCT00974922
Length of Post Operative Dressing After Carpal Tunnel Release
NCT01310218
Smoking Study With Behavioral Therapy for Hypertensive Patients
NCT00879177
A Behavioral Intervention for Reducing Obesity
NCT00892788
Contingency Management to Promote Weight Loss in Low Income Adults
NCT00875199
Exercise or Relaxation for Smoking Cessation
NCT00921388
Women Overcoming and Managing Adversity Now (WOMAN) Study
NCT01324765
A SMART Design for Attendance-based Prize CM
NCT00840151
Bosentan for Poorly Controlled Asthma
NCT00815347
Healthy Activities for Prize Incentives
NCT00717444
Early Range of Motion Following Arthroscopic Rotator Cuff Repair
NCT00845715
Effectiveness of an IMB-based Intervention for Reducing Sweetened Beverages Consumption in Preschool Children
NCT03957148
Contingency Management and Pharmacotherapy for Smoking Cessation
NCT00683280
Contingency Management for Smoking in Substance Abusers
NCT00683033
Contingency Management Treatment Duration
NCT00732342
Topiramate Treatment of Problem Drinkers
NCT00626925
A Pilot SMART Design for Pathological Gamblers
NCT00685724
Brief Therapies for Problem Gambling Substance Abusers
NCT00685048
Anastrozole and Letrozole
NCT00762294
Optical Tomography With Ultrasound Guidance
NCT00908609
Pharmacogenetics of Alcohol: Treatment Implications
NCT00734656
Marijuana Treatment Project - 3
NCT00107588
A Pilot Study to Promote Maternal and Infant Oral Health
NCT00719238
Evaluation of Synthetic Thyrotropin Releasing Hormone (TRH) as a Treatment for Cancer-related Fatigue
NCT00790296
Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT00408070
Zonisamide vs. Placebo in the Treatment of Alcohol Dependence
NCT00595556
Oocyte Cryopreservation: Slow Cooling Versus Vitrification Techniques on Oocyte Survival
NCT00602966
Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects
NCT00802321
Topiramate Alone and in Combination With the Nicotine Patch for Smoking Cessation: A Pilot Study
NCT00755716
Girls In Recovery From Life Stress (GIRLS) Study
NCT00751946
Prevention of Recurrent Aphthous Stomatitis Using Vitamins
NCT00527306
Circulating Adenosine Levels Before and After Intravenous (IV) Persantine
NCT00760708
Cognitive-Behavioral Bibliotherapy for the Treatment of Obsessive Compulsive Disorder in Children and Adolescents
NCT00690729
Group-Based Contingency Management for Substance Abuse Treatment - 1
NCT00249717
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 8 |
| Phase 2 | 15 |
| Phase 3 | 5 |
| Phase 4 | 20 |
Therapeutic Areas
What is open in the UConn Health pipeline
19 recruiting of 178 indexed (11% open); 132 completed (74%).
Phase mix: 25 late (III/IV) vs 23 early (I/II) (balanced across stages).
Top condition: Alcoholism (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
UConn Health: open-pipeline peers nationwide
Peers matched on 178 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
UConn Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 178 trials (± recruiting share)
- Baylor Research Institute · 180 trials · 17% recruiting
- Abbott · 181 trials · 0% recruiting
- Albert Einstein College of Medicine · 175 trials · 11% recruiting
- ViiV Healthcare · 182 trials · 4% recruiting
Sponsors near 11% open enrollment (± trial volume)
- Hartford Hospital · 11% recruiting · 75 trials
- Tufts Medical Center · 11% recruiting · 169 trials
- CAMC Health System · 11% recruiting · 28 trials
- Carnegie Mellon University · 11% recruiting · 37 trials
Related
What to do with this UConn Health page
178 registered trials is a research-attention snapshot, not an endorsement of UConn Health or any single study.
- 19 of UConn Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alcoholism is the condition UConn Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alcoholism trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
UConn Health pipeline card: 178 registered trials from official public datasets.Report a data error.